ID   HROC50 T1 M5
AC   CVCL_1G02
SY   HROC50
DR   CLS; 300839
DR   Wikidata; Q54895297
RX   PubMed=31601052;
CC   From: Linnebacher, Michael; University of Rostock; Rostock; Germany.
CC   Population: Caucasian.
CC   Characteristics: Established from a patient-derived xenograft established in female NSG mice.
CC   Doubling time: 25-40 hours (CLS=300839).
CC   Microsatellite instability: Instable (MSI-high) (Direct_author_submission).
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 8.3
ST   D13S317: 12,13
ST   D16S539: 12,14
ST   D5S818: 11,12,13.1
ST   D7S820: 11,12
ST   TH01: 7,8
ST   TPOX: 7.3,10.3
ST   vWA: 16,17.1
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7UQ ! B-LCL-HROC50
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 15
//
RX   PubMed=31601052; DOI=10.3390/cancers11101520; PMCID=PMC6826890;
RA   Mullins, Christina Susanne
RA   Micheel, Bianca
RA   Matschos, Stephanie
RA   Leuchter, Matthias
RA   Burtin, Florian
RA   Krohn, Mathias
RA   Huhns, Maja
RA   Klar, Ernst
RA   Prall, Friedrich
RA   Linnebacher, Michael
RT   "Integrated biobanking and tumor model establishment of human
RT   colorectal carcinoma provides excellent tools for preclinical
RT   research.";
RL   Cancers (Basel) 11:1520.1-1520.18(2019).
//